Sep 27, 2022
Extra bolagsstämma i Neola Medical (”Bolaget”) hölls idag den 27 september 2022. Med stöd av tillfälliga lagregler hölls den extra bolagsstämman utan fysisk närvaro och de aktieägare som utövat sin rösträtt har gjort detta genom poströstning. Extra bolagsstämman...
Sep 26, 2022
Neola Medical AB will participate at Nordic Life Science Days in Malmö the 28th-29th of September. The 28th of September, at 11.45 (11.45 am) CEO Hanna Sjöström will present the company, the upcoming milestones, and the coming rights issue. Do not miss this!
Sep 22, 2022
BioStock have interviewed CEO Hanna Sjöström to get to know more about the ongoing clinical study with the Neola®-device at University College Cork, Ireland, where the recruitment of 100 babies is completed. In the interview, the upcoming rights issue is also...
Sep 21, 2022
This is a translation of the Swedish press release 2022-09-21 The recruitment of 100 newborn babies to the clinical study NIOMI (Non-Invasive Lung Oxygen Monitoring in Term Infants) at University College Cork, Ireland, have now been completed. Positive subgroup...
Sep 20, 2022
Neola Medical’s CEO Hanna Sjöström presented the company at ABG Sundal Collier’s Investor Day yesterday the 13th of September 2022. See previous press communication about the participation. See the presentation online...
Sep 15, 2022
This is a translation of the Swedish press release 2022-09-15 In this falls investor letter (in Swedish) CEO Hanna Sjöström tells more about the upcoming rights issue that is guaranteed to 80 %, the acquisition of IP rights and the positive results from the first 50...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy
